Ultraviolet radiation (UVR) is implicated in the pathogenesis of various human skin diseases including cutaneous malignancies. The molecular mechanism which underlies this is poorly understood. UVR can activate various signal transduction pathways and to induce the expression of specific genes. This is believed to be transduced through UVR-induced reactive oxygen species (ROS). Protein tyrosine phosphorylation controlled by coordinate action of protein tyrosine kinases (PTKs) and protein tyrosine phosphatases (PTPs) plays an important part in these signal transduction processes. While there is no convincing evidence to show that any PTK can be activated by ROS, PTPs have been shown to be regulated by a redox mechanism. In fact, with a low pKa (usually below 6.0), activate site cysteine of PTPs is an ideal regulatory site for ROS. In preliminary studies, we have found that UVB causes reversible inactivation of PTPs in vitro and in vivo. The inactivation can be prevented and reversed by specific reducing reagents. In vitro, activated PTPs appeared to be more sensitive to UVR, while in keratinocytes, UVB caused approximately 20% loss of PTPs activity in cell extracts. This study is intended to fully characterize UVR-induced inactivation of PTPs in vitro with a number purified PTPs and in vivo with human keratinocytes and epidermal cell lines. We will also identify the PTPs that are most sensitive to UVR and define their implication in UVR- induced signal transduction and pathological consequences. The major experimental approaches include in vitro enzymatic assays, fractionation of cell extracts on chromatographic columns, specific labeling of oxidized PTPs, and in-gel PTP assays. This study should help to open a new field related to skin diseases and it may lead to therapeutic implications.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Center Core Grants (P30)
Project #
5P30AR041943-09
Application #
6590895
Study Section
Special Emphasis Panel (ZAR1)
Project Start
2002-05-01
Project End
2004-04-30
Budget Start
Budget End
Support Year
9
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Type
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37203
Russell, Shirley B; Smith, Joan C; Huang, Minjun et al. (2015) Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases. PLoS Genet 11:e1005568
Velez Edwards, Digna R; Tsosie, Krystal S; Williams, Scott M et al. (2014) Admixture mapping identifies a locus at 15q21.2-22.3 associated with keloid formation in African Americans. Hum Genet 133:1513-23
Duncan, F Jason; Silva, Kathleen A; Johnson, Charles J et al. (2013) Endogenous retinoids in the pathogenesis of alopecia areata. J Invest Dermatol 133:334-43
Takahashi, Keiko; Mernaugh, Raymond L; Friedman, David B et al. (2012) Thrombospondin-1 acts as a ligand for CD148 tyrosine phosphatase. Proc Natl Acad Sci U S A 109:1985-90
Jandova, Jana; Eshaghian, Alex; Shi, Mingjian et al. (2012) Identification of an mtDNA mutation hot spot in UV-induced mouse skin tumors producing altered cellular biochemistry. J Invest Dermatol 132:421-8
Jandova, Jana; Shi, Mingjian; Norman, Kimberly G et al. (2012) Somatic alterations in mitochondrial DNA produce changes in cell growth and metabolism supporting a tumorigenic phenotype. Biochim Biophys Acta 1822:293-300
Sundberg, J P; Taylor, D; Lorch, G et al. (2011) Primary follicular dystrophy with scarring dermatitis in C57BL/6 mouse substrains resembles central centrifugal cicatricial alopecia in humans. Vet Pathol 48:513-24
Harries, M J; Sun, J; Paus, R et al. (2010) Management of alopecia areata. BMJ 341:c3671
Yang, Jinming; Splittgerber, Ryan; Yull, Fiona E et al. (2010) Conditional ablation of Ikkb inhibits melanoma tumor development in mice. J Clin Invest 120:2563-74
Russell, Shirley B; Russell, James D; Trupin, Kathryn M et al. (2010) Epigenetically altered wound healing in keloid fibroblasts. J Invest Dermatol 130:2489-96

Showing the most recent 10 out of 139 publications